+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 252 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5311178
UP TO OFF until Dec 31st 2022
The Global Circulating Tumor Cell Market size was estimated at USD 9,614.20 million in 2021, USD 10,932.26 million in 2022, and is projected to grow at a CAGR 13.88% to reach USD 20,977.18 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Circulating Tumor Cell to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Specimen, the market was studied across Blood, Bone Marrow, and Other Body Fluids.
  • Based on Technology, the market was studied across CTC Analysis, CTC Detection & Enrichment Methods, and CTC Direct Detection Methods. The CTC Detection & Enrichment Methods is further studied across Combined Methods, Density-based Separation, Immunocapture, and Size-based Separation. The Immunocapture is further studied across Negative Selection and Positive Selection. The Size-based Separation is further studied across Membrane-based and Microfluidic-based.
  • Based on Product, the market was studied across Blood Collection Tubes, Devices or Systems, and Kits & Reagents.
  • Based on Application, the market was studied across Clinical/ Liquid Biopsy and Research. The Clinical/ Liquid Biopsy is further studied across Risk Assessment and Screening and Monitoring. The Research is further studied across Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Circulating Tumor Cell market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Circulating Tumor Cell Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Circulating Tumor Cell Market, including Advanced Cell Diagnostics, Inc., ApoCell, Inc., Aviva Biosciences, Bio-Techne Corporation, BioCep Ltd., BIOCEPT, INC., BioFluidica, Biolidics Limited, Canopus Bioscience Ltd., Creatv MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, NanoString Technologies, Inc., Precision for Medicine, QIAGEN, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, and Vitatex, Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Circulating Tumor Cell Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Circulating Tumor Cell Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Circulating Tumor Cell Market?
4. What is the competitive strategic window for opportunities in the Global Circulating Tumor Cell Market?
5. What are the technology trends and regulatory frameworks in the Global Circulating Tumor Cell Market?
6. What is the market share of the leading vendors in the Global Circulating Tumor Cell Market?
7. What modes and strategic moves are considered suitable for entering the Global Circulating Tumor Cell Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased spending in cancer-related therapies
5.1.1.2. Growing prevalence of cancer across the globe
5.1.2. Restraints
5.1.2.1. Lack of awareness about CTC therapeutics
5.1.3. Opportunities
5.1.3.1. Technological advancements in bioengineering and biomedical practices
5.1.3.2. Demand for minimally invasive diagnostics in recent years
5.1.4. Challenges
5.1.4.1. Stringent government regulations for the approval of CTC technologies
5.2. Cumulative Impact of COVID-19
6. Circulating Tumor Cell Market, by Specimen
6.1. Introduction
6.2. Blood
6.3. Bone Marrow
6.4. Other Body Fluids
7. Circulating Tumor Cell Market, by Technology
7.1. Introduction
7.2. CTC Analysis
7.3. CTC Detection & Enrichment Methods
7.3.1. Combined Methods
7.3.2. Density-based Separation
7.3.3. Immunocapture
7.3.3.1. Negative Selection
7.3.3.2. Positive Selection
7.3.4. Size-based Separation
7.3.4.1. Membrane-based
7.3.4.2. Microfluidic-based
7.4. CTC Direct Detection Methods
8. Circulating Tumor Cell Market, by Product
8.1. Introduction
8.2. Blood Collection Tubes
8.3. Devices or Systems
8.4. Kits & Reagents
9. Circulating Tumor Cell Market, by Application
9.1. Introduction
9.2. Clinical/ Liquid Biopsy
9.2.1. Risk Assessment
9.2.2. Screening and Monitoring
9.3. Research
9.3.1. Cancer Stem Cell & Tumorigenesis Research
9.3.2. Drug/Therapy Development
10. Americas Circulating Tumor Cell Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Circulating Tumor Cell Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Circulating Tumor Cell Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Advanced Cell Diagnostics, Inc.
14.2. ApoCell, Inc.
14.3. Aviva Biosciences
14.4. Bio-Techne Corporation
14.5. BioCep Ltd.
14.6. BIOCEPT, INC.
14.7. BioFluidica
14.8. Biolidics Limited
14.9. Canopus Bioscience Ltd.
14.10. Creatv MicroTech, Inc.
14.11. Epic Sciences
14.12. Fluxion Biosciences, Inc.
14.13. Greiner Bio One International GmbH
14.14. Ikonisys Inc.
14.15. IVDiagnostics
14.16. LungLife AI, Inc.
14.17. Menarini Silicon Biosystems
14.18. Miltenyi Biotec
14.19. NanoString Technologies, Inc.
14.20. Precision for Medicine
14.21. QIAGEN
14.22. Rarecells Diagnostics
14.23. ScreenCell
14.24. STEMCELL Technologies, Inc.
14.25. Sysmex Corporation
14.26. Vitatex, Inc
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CIRCULATING TUMOR CELL MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET DYNAMICS
FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2021 VS 2027 (%)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2027
FIGURE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 43. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2027
FIGURE 45. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 52. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2027
FIGURE 54. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2019-2027 (USD MILLION)
FIGURE 61. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 62. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, 2019-2027 (USD MILLION)
FIGURE 63. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 64. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, 2019-2027 (USD MILLION)
FIGURE 65. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 66. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 68. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2027
FIGURE 70. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. CANADA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 76. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 77. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2027
FIGURE 78. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 80. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2027
FIGURE 82. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. CHINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. INDIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 95. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 96. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2027
FIGURE 97. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. ITALY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. QATAR CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 109. GLOBAL CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 110. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CIRCULATING TUMOR CELL MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 94. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2019-2027 (USD MILLION)
TABLE 95. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY STATE, 2019-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 100. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY REGION, 2019-2027 (USD MILLION)
TABLE 105. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY STATE, 2019-2027 (USD MILLION)
TABLE 107. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 110. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 112. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 115. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 120. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 122. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 127. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 128. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 129. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 130. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 132. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 133. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 135. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 137. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 138. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 139. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 140. CANADA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 142. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 143. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 144. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 145. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 147. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 148. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 150. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 152. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 153. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 154. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 155. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 156. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 157. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 158. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 159. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 160. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 161. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 164. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 165. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 166. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 167. CHINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 169. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 170. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 171. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 172. INDIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 174. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 175. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 176. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 179. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 180. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 181. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 182. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 183. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 184. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 185. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 186. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 187. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 188. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 189. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 190. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 191. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 192. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 194. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 195. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 196. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 197. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 199. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 200. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 201. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 202. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 203. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 204. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 205. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 206. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 208. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 209. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 210. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 211. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 212. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 213. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 214. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 215. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 216. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 223. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 224. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 225. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 226. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 227. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 228. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 229. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 230. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 231. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 232. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 233. ITALY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 235. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 236. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 237. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 238. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 239. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 240. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 241. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 242. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 243. QATAR CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 244. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 245. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 246. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 247. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 248. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 249. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 250. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 251. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 252. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 253. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 254. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 255. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 256. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 257. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 258. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 259. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 260. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 261. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 262. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 263. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 265. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 266. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 267. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 273. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 274. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 275. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 276. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 277. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 278. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 279. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 280. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 281. GLOBAL CIRCULATING TUMOR CELL MARKET RANKING
TABLE 282. GLOBAL CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2021
TABLE 283. GLOBAL CIRCULATING TUMOR CELL MARKET MERGER & ACQUISITION
TABLE 284. GLOBAL CIRCULATING TUMOR CELL MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 285. GLOBAL CIRCULATING TUMOR CELL MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 286. GLOBAL CIRCULATING TUMOR CELL MARKET INVESTMENT & FUNDING
TABLE 287. GLOBAL CIRCULATING TUMOR CELL MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 288. GLOBAL CIRCULATING TUMOR CELL MARKET: LICENSE & PRICING

Companies Mentioned

  • Advanced Cell Diagnostics, Inc.
  • ApoCell, Inc.
  • Aviva Biosciences
  • Bio-Techne Corporation
  • BioCep Ltd.
  • BIOCEPT, INC.
  • BioFluidica
  • Biolidics Limited
  • Canopus Bioscience Ltd.
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc.
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • IVDiagnostics
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec
  • NanoString Technologies, Inc.
  • Precision for Medicine
  • QIAGEN
  • Rarecells Diagnostics
  • ScreenCell
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Vitatex, Inc

Methodology

Loading
LOADING...